News Image
CNBCTV18

Sensex Today | Stock Market LIVE Updates: All sectoral indices trade in red; Nifty Pharma down 500 pts

Published on 26/09/2025 11:53 AM

Larsen & Toubro (L&T) shares emerged as the top gainers on the Nifty 50, outperforming even as the benchmark index extended its decline for the sixth straight session.

Read Full Article

RITES surged on an order win, with trading volume hitting the highest since July 2 as 2.1 crore shares changed hands versus a 20-day average of 3.7 lakh.

Key technical levels are the 50-DMA at ₹261 and 100-DMA at ₹269, though the stock remains 36% below its peak.

Nitin Raheja, Julius Baer India On CNBC-TV18

Canara Bank arm Canara HSBC Life Insurance has filed an updated DRHP with SEBI

Along with the frontlines indices, all major sectoral indices are trading in red.

As the bears take over the markets, the Nifty 50 index has extended its losses even further.

According to the Wall Street Journal, the US intends to require semiconductor companies to produce domestically an amount of chips equal to what their customers currently import from overseas suppliers.

Read Full Article

The shares of Manyavaar or Vedant Fashions have hit a record low

Carysil stated that the 50% US tariffs on kitchen equipment do not affect the company. Their kitchen sinks are not classified as kitchen cabinets, and the company does not export kitchen cabinets or bathroom vanities.

 

Shares of Vodafone Idea are now down 5.5% after continuing their losses. Following the government’s request for further time, the SC postponed its decision about the AGR dues until October 6.

 

The Supreme Court has deferred the hearing on Vodafone Idea’s adjusted gross revenue (AGR) case to October 6, after the Solicitor General requested additional time on behalf of the Department of Telecommunications (DoT).

Here is a stock recommendation by Sudeep Shah of SBI Securities

The Supreme Court has deferred the Vodafone AGR Hearing.

 

Cartrade and RACL Geartech volumes surge, SJS Enterprises lags behind the 20-day average.

The Nifty 50 index has extended its losses, falling to the day’s low

The Nifty Midcap index is trading with a major decline of nearly 600 points.

Here are some of the biggest volume buzzers among the Nifty 500 stocks.

Sonal Varma, Managing director & chief economist- India and Asia Ex-Japan, Nomura Financial Advisory & Securities (India)

 

Market Watch: Shivangi Sarda, Motilal Oswal Financial Services

Sajjid Chinoy, Head of Asia Economic Research, JPMorgan

On Friday, September 26, JSW Steel Ltd.’s stock rose 1.5% from the day’s lows after the Supreme Court reversed its own ruling regarding the company’s purchase of Bhushan Power and Steel.

Supreme Court overturns its earlier judgment and approves JSW’s resolution plan for Bhushan Steel.

Gopal Kabra, CEO & CMD of GK Energy

Habil F Khorakiwala, Founder and Chairman of Wockhardt Group, clarified that the antibiotic Zaynich is manufactured entirely in Europe, not India, and therefore will be subject to European tariffs rather than Indian tariffs.

Read Full Article

Samiran Chakraborty, Chief Economist, India, Citi

 

Soumya Kanti Ghosh, Group Chief Economic Advisor, State Bank of India

All major sectoral indices are trading in the red. However, the Auto sector index is the only one trading in green with marginal gains.

 

Balaji Subramanian, VP of IIFL Capital Services, says the focus on Vodafone Idea has shifted to whether the Supreme Court grants the government leeway in resolving the adjusted gross revenue (AGR) matter. With a 49% stake in the company, the government aims to maintain a three-player telecom market and is seeking official clarity from the Court before pursuing relief measures, such as extending moratoriums, adjusting payment timelines, or changing the NPV of liabilities. The tone has turned positive, pending the Court’s decision.

Aarti Drugs shares fell 6.02% to ₹476.55 on September 26, down from the previous close of ₹507.10.

The stock, part of BSE 1000 and BSE AllCap, has a market capitalisation of ₹4,349.47 crore and a traded volume of 1,51,840 shares.

Over the past five trading sessions, the stock has declined 7.76%, with a price-to-earnings (P/E) ratio of 25.97.

The Nifty Pharma index is under pressure after Donald Trump’s tariff threat on pharma

NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.